Un­der pres­sure? FDA pen­cils in June re­view dates for Pfiz­er, Mod­er­na Covid vac­cines for kids, plus No­vavax EUA

The FDA on Fri­day set up a slate of June meet­ing dates to re­view Covid-19 vac­cine sub­mis­sions — even though not all the plans are in yet.

The agency re­served June 8, 21 and 22 for vir­tu­al meet­ings of the Vac­cines and Re­lat­ed Bi­o­log­i­cal Prod­ucts Ad­vi­so­ry Com­mit­tee (VRB­PAC) to re­view Mod­er­na and Pfiz­er-BioN­Tech emer­gency use au­tho­riza­tions for younger age groups. While Mod­er­na sub­mit­ted its emer­gency use au­tho­riza­tion for chil­dren aged 6 months to 6 years to the FDA on Thurs­day, Pfiz­er and BioN­Tech have yet to do so.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER